News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
652,545 Results
Type
Article (32941)
Company Profile (640)
Press Release (618964)
Multimedia
Podcasts (53)
Webinars (11)
Section
Business (197655)
Career Advice (2102)
Deals (36219)
Drug Delivery (102)
Drug Development (77695)
Employer Resources (163)
FDA (15469)
Job Trends (14742)
News (332972)
Policy (28853)
Tag
Academia (1398)
Academic (1)
Accelerated approval (5)
Adcomms (14)
Allergies (85)
Alliances (47008)
ALS (94)
Alzheimer's disease (1300)
Antibody-drug conjugate (ADC) (137)
Approvals (15461)
Artificial intelligence (247)
Autoimmune disease (28)
Automation (13)
Bankruptcy (376)
Best Places to Work (10959)
BIOSECURE Act (22)
Biosimilars (97)
Biotechnology (437)
Bladder cancer (76)
Brain cancer (26)
Breast cancer (250)
Cancer (2133)
Cardiovascular disease (167)
Career advice (1734)
Career pathing (32)
CAR-T (149)
Cell therapy (427)
Cervical cancer (17)
Clinical research (63724)
Collaboration (843)
Compensation (522)
Complete response letters (27)
COVID-19 (2188)
CRISPR (42)
C-suite (259)
Cystic fibrosis (98)
Data (2119)
Decentralized trials (2)
Denatured (3)
Depression (49)
Diabetes (252)
Diagnostics (6333)
Digital health (17)
Diversity (3)
Diversity, equity & inclusion (37)
Drug discovery (112)
Drug pricing (101)
Drug shortages (24)
Duchenne muscular dystrophy (88)
Earnings (83213)
Editorial (37)
Employer branding (24)
Employer resources (139)
Events (109980)
Executive appointments (744)
FDA (16650)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (737)
Gene editing (109)
Generative AI (24)
Gene therapy (307)
GLP-1 (717)
Government (2917)
Grass and pollen (6)
Guidances (51)
Healthcare (16562)
Huntington's disease (23)
IgA nephropathy (29)
Immunology and inflammation (128)
Indications (29)
Infectious disease (2323)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (97)
Interviews (424)
IPO (17198)
IRA (41)
Job creations (4219)
Job search strategy (1437)
Kidney cancer (10)
Labor market (36)
Layoffs (539)
Leadership (19)
Legal (7162)
Liver cancer (74)
Lung cancer (304)
Lymphoma (136)
Machine learning (4)
Management (58)
Manufacturing (321)
MASH (66)
Medical device (13706)
Medtech (13711)
Mergers & acquisitions (19568)
Metabolic disorders (669)
Multiple sclerosis (81)
NASH (18)
Neurodegenerative disease (98)
Neuropsychiatric disorders (31)
Neuroscience (1851)
NextGen: Class of 2025 (6074)
Non-profit (2054)
Now hiring (40)
Obesity (360)
Opinion (247)
Ovarian cancer (70)
Pain (93)
Pancreatic cancer (81)
Parkinson's disease (149)
Partnered (19)
Patents (237)
Patient recruitment (109)
Peanut (48)
People (56958)
Pharmaceutical (132)
Pharmacy benefit managers (16)
Phase I (20074)
Phase II (28485)
Phase III (21079)
Pipeline (1194)
Policy (135)
Postmarket research (1917)
Preclinical (8098)
Press Release (64)
Prostate cancer (102)
Psychedelics (35)
Radiopharmaceuticals (260)
Rare diseases (377)
Real estate (5771)
Recruiting (64)
Regulatory (20708)
Reports (35)
Research institute (1364)
Resumes & cover letters (330)
Rett syndrome (4)
RNA editing (5)
RSV (43)
Schizophrenia (76)
Series A (135)
Series B (90)
Service/supplier (26)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (145)
Sponsored (21)
Startups (3884)
State (2)
Stomach cancer (12)
Supply chain (70)
Tariffs (42)
The Weekly (49)
Vaccines (648)
Venture capitalists (44)
Weight loss (244)
Women's health (24)
Worklife (19)
Date
Today (175)
Last 7 days (873)
Last 30 days (2642)
Last 365 days (33178)
2025 (10676)
2024 (35696)
2023 (40464)
2022 (50925)
2021 (54152)
2020 (51206)
2019 (42403)
2018 (32401)
2017 (32565)
2016 (30786)
2015 (36174)
2014 (28870)
2013 (23833)
2012 (25445)
2011 (25609)
2010 (23452)
Location
Africa (669)
Alabama (59)
Alaska (6)
Arizona (163)
Arkansas (11)
Asia (40047)
Australia (6523)
California (6180)
Canada (1995)
China (528)
Colorado (265)
Connecticut (280)
Delaware (141)
Europe (87249)
Florida (868)
Georgia (204)
Hawaii (1)
Idaho (56)
Illinois (480)
India (28)
Indiana (318)
Iowa (12)
Japan (156)
Kansas (100)
Kentucky (23)
Louisiana (11)
Maine (65)
Maryland (766)
Massachusetts (4752)
Michigan (233)
Minnesota (394)
Mississippi (2)
Missouri (82)
Montana (30)
Nebraska (22)
Nevada (61)
New Hampshire (67)
New Jersey (1742)
New Mexico (30)
New York (1715)
North Carolina (1060)
North Dakota (7)
Northern California (2671)
Ohio (197)
Oklahoma (11)
Oregon (41)
Pennsylvania (1365)
Puerto Rico (12)
Rhode Island (35)
South America (1054)
South Carolina (21)
South Dakota (1)
Southern California (2258)
Tennessee (93)
Texas (899)
United States (23098)
Utah (179)
Virginia (144)
Washington D.C. (57)
Washington State (573)
West Virginia (3)
Wisconsin (52)
652,545 Results for "staar surgical company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference.
June 5, 2024
·
1 min read
Business
STAAR Surgical Reports First Quarter 2024 Results
STAAR Surgical Company, a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses for myopia, astigmatism and presbyopia, reported financial results for the first quarter ended March 29, 2024.
May 7, 2024
·
19 min read
Business
STAAR Surgical to Report First Quarter Results on May 7, 2024
STAAR Surgical Company today announced that it will release financial results for the first quarter ended March 29, 2024, on Tuesday, May 7, 2024, after the market close.
April 29, 2024
·
2 min read
Business
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
STAAR Surgical Company today announced preliminary net sales for the first quarter ended March 29, 2024, are expected to be in excess of $77 million with U.S. ICL sales expected to be $5 million for the quarter.
April 4, 2024
·
4 min read
Biotech Beach
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
STAAR Surgical Company, a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses for myopia, astigmatism and presbyopia, announced that more than three million ICLs have been sold globally.
March 18, 2024
·
3 min read
Business
STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
STAAR Surgical Company announces another milestone achieved on its U.S. Highway 93 go-to-market program – a strategic agreement with IQ Laser Vision, a leader in providing clear vision to clients with locations across California and Texas, and a top EVO ICL practice in North America.
May 7, 2024
·
9 min read
Business
STAAR Surgical to Report Fourth Quarter Results on February 26, 2024
STAAR Surgical Company today announced that it will release financial results for the fourth quarter ending December 29, 2023, on Monday, February 26, 2024, after the market close.
February 19, 2024
·
2 min read
Business
STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision
STAAR Surgical Company and SharpeVision announced a strategic agreement to provide EVO ICL lenses as a first choice for patients seeking visual freedom from contact lenses and glasses.
January 23, 2024
·
8 min read
Business
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
STAAR Surgical Company, a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses for myopia, astigmatism and presbyopia, announced Nancy Sabin has been named Chief Marketing Officer and Nathaniel Sisitsky has been named General Counsel.
May 1, 2024
·
4 min read
Business
STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors
STAAR Surgical Company announced the appointment of Arthur Butcher, Executive Vice President and Group President, MedSurg and Asia Pacific for Boston Scientific, and Wei Jiang, retired Executive Vice President and President of Bayer Pharmaceuticals Region China & APAC, to its Board of Directors, effective March 12, 2024.
March 12, 2024
·
4 min read
1 of 65,255
Next
